398 related articles for article (PubMed ID: 20592948)
1. Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?
Henriques A; Pitzer C; Schneider A
Front Neurosci; 2010 Jun; 4():32. PubMed ID: 20592948
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
Pitzer C; Krüger C; Plaas C; Kirsch F; Dittgen T; Müller R; Laage R; Kastner S; Suess S; Spoelgen R; Henriques A; Ehrenreich H; Schäbitz WR; Bach A; Schneider A
Brain; 2008 Dec; 131(Pt 12):3335-47. PubMed ID: 18835867
[TBL] [Abstract][Full Text] [Related]
3. Neurotrophic Peptides: Potential Drugs for Treatment of Amyotrophic Lateral Sclerosis and Alzheimer's disease.
Ciesler J; Sari Y
Open J Neurosci; 2013 Apr; 3():. PubMed ID: 23795307
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophic factors and amyotrophic lateral sclerosis.
Ekestern E
Neurodegener Dis; 2004; 1(2-3):88-100. PubMed ID: 16908980
[TBL] [Abstract][Full Text] [Related]
5. Experimental rationale for the therapeutic use of neurotrophins in amyotrophic lateral sclerosis.
Seeburger JL; Springer JE
Exp Neurol; 1993 Nov; 124(1):64-72. PubMed ID: 8282083
[TBL] [Abstract][Full Text] [Related]
6. Stem cell therapy in amyotrophic lateral sclerosis.
Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic news in ALS.
Corcia P; Beltran S; Bakkouche SE; Couratier P
Rev Neurol (Paris); 2021 May; 177(5):544-549. PubMed ID: 33781562
[TBL] [Abstract][Full Text] [Related]
8. A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders.
Mazibuko Z; Choonara YE; Kumar P; Du Toit LC; Modi G; Naidoo D; Pillay V
J Pharm Sci; 2015 Apr; 104(4):1213-29. PubMed ID: 25559087
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.
Jeon GS; Im W; Shim YM; Lee M; Kim MJ; Hong YH; Seong SY; Kim M; Sung JJ
Neurochem Res; 2016 Apr; 41(4):913-23. PubMed ID: 26646002
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor system in amyotrophic lateral sclerosis.
Wilczak N; Keyser J
Endocr Dev; 2005; 9():160-169. PubMed ID: 15879696
[TBL] [Abstract][Full Text] [Related]
11. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
[TBL] [Abstract][Full Text] [Related]
12. [Apoptosis and neurotrophic factors].
Suzuki H
No To Hattatsu; 1999 Mar; 31(2):129-34. PubMed ID: 10191634
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
14. Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis.
Ciervo Y; Ning K; Jun X; Shaw PJ; Mead RJ
Mol Neurodegener; 2017 Nov; 12(1):85. PubMed ID: 29132389
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies.
Gittings LM; Sattler R
Fac Rev; 2020; 9():12. PubMed ID: 33659944
[TBL] [Abstract][Full Text] [Related]
16. The past, present and future of stem cell clinical trials for ALS.
Thomsen GM; Gowing G; Svendsen S; Svendsen CN
Exp Neurol; 2014 Dec; 262 Pt B():127-37. PubMed ID: 24613827
[TBL] [Abstract][Full Text] [Related]
17. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.
Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR
Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury.
Nicaise C; Mitrecic D; Falnikar A; Lepore AC
World J Stem Cells; 2015 Mar; 7(2):380-98. PubMed ID: 25815122
[TBL] [Abstract][Full Text] [Related]
20. Amyotrophic lateral sclerosis - looking for pathogenesis and effective therapy.
Naganska E; Matyja E
Folia Neuropathol; 2011; 49(1):1-13. PubMed ID: 21455838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
